National Aeronautics and Space Administration June 30, 2006 – Federal Register Recent Federal Regulation Documents
Results 1 - 2 of 2
Notice of Intent To Grant Partially Exclusive License
This notice is issued in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant a partially exclusive license in the United States to practice the inventions described and claimed in ``Ordered Biological Nanostructures Formed From Chaperonin Polypeptides,'' ARC-14744-1 and ``A Versatile Platform for Nanotechnology Based on Circular Permutations of Chaperonin Protein,'' ARC-14744-2, to Cambrios Technologies, having its principal place of business in Mountain View, California. The patent rights in this invention have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective partially-exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.
NASA International Space Station Independent Safety Task Force; Meeting
In accordance with the Federal Advisory Committee Act, Public Law 92-463, as amended, the National Aeronautics and Space Administration announces a forthcoming meeting of the International Space Station Independent Safety Task Force (IISTF).
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
